Robot‐assisted retinal vein cannulation in an in vivo porcine retinal vein occlusion model

To evaluate the feasibility of robot‐assisted retinal vein cannulation for retinal vein occlusion.

[1]  Alexandros N Stangos,et al.  THE RATIONALE OF RETINAL ENDOVASCULAR FIBRINOLYSIS IN THE TREATMENT OF RETINAL VEIN OCCLUSION: From Experimental Data to Clinical Application , 2012, Retina.

[2]  E. Opremcak.  Radial optic neurotomy. , 2008, Ophthalmology.

[3]  E. Opremcak,et al.  RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSION: 117 Consecutive Cases , 2006, Retina.

[4]  H. Quiroz-Mercado,et al.  RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSION: Results of the Pan-American Collaborative Retina Study Group (PACORES) , 2008, Retina.

[5]  L. Hattenbach,et al.  Experimental endoscopic endovascular cannulation: a novel approach to thrombolysis in retinal vessel occlusion. , 2012, Investigative ophthalmology & visual science.

[6]  S. Takeuchi,et al.  Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. , 2004, American journal of ophthalmology.

[7]  J. Weiss,et al.  Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. , 2001, Ophthalmology.

[8]  G. Soubrane,et al.  Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study , 2000, British Journal of Ophthalmology.

[9]  A. Cruess,et al.  Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus , 2015, Ophthalmologica.

[10]  Larry Kagemann,et al.  An update on retinal circulation assessment technologies , 2003, Current eye research.

[11]  L. Schwamm,et al.  Endovascular Approaches to Acute Stroke, Part 1: Drugs, Devices, and Data , 2009, American Journal of Neuroradiology.

[12]  Jon Atli Benediktsson,et al.  Automatic retinal oximetry. , 2006, Investigative ophthalmology & visual science.

[13]  A. Kampik,et al.  Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. , 2012, The New England journal of medicine.

[14]  Tien Yin Wong,et al.  The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. , 2010, Ophthalmology.

[15]  Bernd Junker,et al.  Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. , 2007, Ophthalmology.

[16]  L. Bynoe,et al.  RETINAL ENDOVASCULAR SURGERY FOR CENTRAL RETINAL VEIN OCCLUSION: Initial Experience of Four Surgeons , 2004, Retina.

[17]  Yasushi Ikuno,et al.  COMPARISON OF SURGICAL TREATMENTS FOR CENTRAL RETINAL VEIN OCCLUSION; RON VS. CANNULATION OF TISSUE PLASMINOGEN ACTIVATOR INTO THE RETINAL VEIN , 2009, Retina.

[18]  Einar Stefánsson,et al.  Oxygen saturation in central retinal vein occlusion. , 2010, American journal of ophthalmology.

[19]  R. Klein,et al.  The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. , 2000, Transactions of the American Ophthalmological Society.

[20]  Matus Rehak,et al.  Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities , 2008, Current eye research.

[21]  M. Maia,et al.  Intravitreal Bevacizumab (Avastin(R)) for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Results of the Pan-American Collaborative Retina Study Group (PACORES) , 2007 .

[22]  T. Missotten,et al.  Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion , 2015, Acta ophthalmologica.

[23]  I. Scharrer,et al.  RETINAL VEIN OCCLUSION AND LOW-DOSE FIBRINOLYTIC THERAPY (R.O.L.F.): A Prospective, Randomized, Controlled Multicenter Study of Low-Dose Recombinant Tissue Plasminogen Activator Versus Hemodilution in Retinal Vein Occlusion , 2009, Retina.

[24]  R. MacLaren.  Gene Therapy for Retinal Disease: What Lies Ahead , 2015, Ophthalmologica.

[25]  Cameron N. Riviere,et al.  Physiological tremor amplitude during retinal microsurgery , 2002, Proceedings of the IEEE 28th Annual Northeast Bioengineering Conference (IEEE Cat. No.02CH37342).

[26]  P. Verhamme,et al.  Thrombolytic efficacy of recombinant human microplasmin in a canine model of copper coil-induced coronary artery thrombosis , 2010, Journal of Thrombosis and Thrombolysis.

[27]  I. Constable,et al.  Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. , 1995, Archives of ophthalmology.

[28]  R D Sperduto,et al.  Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. , 1993, Ophthalmology.

[29]  Y. Rosen,et al.  Recombinant tissue plasminogen activators (rtPA): A review , 2015, Clinical pharmacology and therapeutics.

[30]  T. Neumann-Haefelin,et al.  Randomized, Placebo-Controlled, Dose-Ranging Clinical Trial of Intravenous Microplasmin in Patients With Acute Ischemic Stroke , 2009, Stroke.

[31]  Dominiek Reynaerts,et al.  Design and realisation of a novel robotic manipulator for retinal surgery , 2013, 2013 IEEE/RSJ International Conference on Intelligent Robots and Systems.

[32]  R. Spaide,et al.  Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. , 2015, JAMA ophthalmology.

[33]  Jeroen Kalkman,et al.  Heartbeat-induced axial motion artifacts in optical coherence tomography measurements of the retina. , 2011, Investigative ophthalmology & visual science.

[34]  M. Zimmerman,et al.  Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. , 1994, American journal of ophthalmology.

[35]  R. Clemett,et al.  An anatomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusions. , 1993, Australian and New Zealand journal of ophthalmology.

[36]  Akira Arakawa,et al.  Endovascular cannulation with a microneedle for central retinal vein occlusion. , 2013, JAMA ophthalmology.

[37]  Jeffrey N. Weiss,et al.  Injection of Tissue Plasminogen Activator into a Branch Retinal Vein in Eyes with Central Retinal Vein Occlusion. , 2003 .

[38]  P. Kolar.  Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data , 2014, Journal of ophthalmology.